Optimer Pharmaceuticals, Inc. (OPTR)

[surf1944]

8:01AM Optimer Pharma announced that DIFICID tablets were Approved in Australia (OPTR) 14.86 : Co announced that the Therapeutic Goods Administration, the Australian regulatory body for therapeutic goods such as medicines, has approved DIFICID tablets for the treatment of confirmed Clostridium difficile infection in adults. DIFICID will be available to patients in Australia starting May 14, 2013 from Specialised Therapeutics Australia Pty, which licensed exclusive rights to fidaxomicin in Australia and New Zealand from Optimer. STA is also responsible for registration and commercialization of DIFICID in New Zealand.